Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengzhao Yang

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Endocrinology|March 6, 2025
A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetesYongjian Zhou, Zecheng Yang, Shixi Zhang, et al.
BMC Infectious Diseases|February 25, 2025
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort studyBenchen Rao, Daming Wang, Mengzhao Yang, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
A retrospective cohort study of the efficacy and safety of oral azvudine <i>versus</i> nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 yearsBo Yu, Haiyu Wang, Guangming Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 22, 2025
The Antiviral Efficacy and Safety of Azvudine in Hospitalized SARS-CoV-2 Infected Patients with Liver Diseases Based on a Multicenter, Retrospective Cohort StudyJunyi Sun, Mengzhao Yang, Guanyue Su, et al.
Iscience|February 25, 2025
Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetesGuanyue Su, Silin Li, Donghua Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2025
Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Real-World StudyRanran Sun, Haiyu Wang, Junyi Sun, et al.
The Journal of Infection|November 19, 2024
Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort studyZhigang Ren, Mengzhao Yang, Guanyue Su, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort studyHaiyu Wang, Guangying Cui, Ming Cheng, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Endocrinology|March 6, 2025
A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetesYongjian Zhou, Zecheng Yang, Shixi Zhang, et al.
BMC Infectious Diseases|February 25, 2025
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort studyBenchen Rao, Daming Wang, Mengzhao Yang, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
A retrospective cohort study of the efficacy and safety of oral azvudine <i>versus</i> nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 yearsBo Yu, Haiyu Wang, Guangming Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 22, 2025
The Antiviral Efficacy and Safety of Azvudine in Hospitalized SARS-CoV-2 Infected Patients with Liver Diseases Based on a Multicenter, Retrospective Cohort StudyJunyi Sun, Mengzhao Yang, Guanyue Su, et al.
Iscience|February 25, 2025
Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetesGuanyue Su, Silin Li, Donghua Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2025
Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Real-World StudyRanran Sun, Haiyu Wang, Junyi Sun, et al.
The Journal of Infection|November 19, 2024
Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort studyZhigang Ren, Mengzhao Yang, Guanyue Su, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort studyHaiyu Wang, Guangying Cui, Ming Cheng, et al.
Pageof 2